HMOX1 and breast cancer: Molecular docking simulations reveal how hemin and related compounds interact with HO-1, offering insights into oxidative stress regulation and suggesting that controlled delivery of hemin or its analogs has the potential of leading the way to the development of innovative targeted BC therapies [276].